• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性前列腺切除术:1001例病例的病理结果与其他主要系列研究的比较及随时间变化情况

Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time.

作者信息

Bott Simon R J, Freeman A Alex, Stenning Sally, Cohen Jonathan, Parkinson M Constance

机构信息

Institute of Urology, University College London, London, UK.

出版信息

BJU Int. 2005 Jan;95(1):34-9. doi: 10.1111/j.1464-410X.2005.05245.x.

DOI:10.1111/j.1464-410X.2005.05245.x
PMID:15638892
Abstract

OBJECTIVE

To examine the preoperative features and pathological outcomes of clinical significance of 1001 consecutive essentially unscreened men who had a radical prostatectomy (RP) in the UK between 1988 and 2002, and their changes over time.

PATIENTS AND METHODS

The details of men whose RP specimen was submitted for analysis were entered into the RP database held at the University College Hospital, London; the National Health Service and private patients of 17 surgeons were included. The age, mode of diagnosis, preoperative prostate specific antigen (PSA) level, biopsy and RP findings were compared over time.

RESULTS

The mean (range) age of the men was 62 (40-76) years, the median PSA 8 (0.1-146) ng/mL and the median biopsy Gleason sum score 6; these preoperative features did not change over the study period. The diagnosis of prostate cancer was made by transurethral resection of the prostate alone in 48 men (5%). The maximum number of patients receiving neoadjuvant androgen ablation was 21 (33%) in 1996, and subsequently declined. The median (range) RP Gleason sum score was 7 (4-9). The biopsy Gleason score correlated with the prostatectomy Gleason score in 252 (47%) of 536 men, being lower in 170 (32%) and higher in 113 (21%). The median tumour volume was 2 mL (focus of invasive acini - 31 mL) and the incidence of positive intra- and extraprostatic margins was 52%. Both tumour volume and extraprostatic margin positivity declined with time.

CONCLUSIONS

The preoperative features and pathological findings from this UK series are similar to those of other reported cohorts from unscreened populations. The incidence of positive extraprostatic surgical margins, tumour volume and stage decreased with time.

摘要

目的

研究1988年至2002年间在英国连续接受根治性前列腺切除术(RP)的1001例基本未经筛查的男性患者的术前特征及具有临床意义的病理结果,以及这些特征随时间的变化情况。

患者与方法

将提交RP标本进行分析的男性患者详细信息录入伦敦大学学院医院保存的RP数据库;纳入了17位外科医生的国民医疗服务体系(NHS)患者和私人患者。对不同时间段患者的年龄、诊断方式、术前前列腺特异性抗原(PSA)水平、活检及RP结果进行比较。

结果

这些男性患者的平均(范围)年龄为62(40 - 76)岁,PSA中位数为8(0.1 - 146)ng/mL,活检Gleason总分中位数为6分;这些术前特征在研究期间未发生变化。仅通过经尿道前列腺切除术诊断出前列腺癌的患者有48例(5%)。1996年接受新辅助雄激素剥夺治疗的患者最多,为21例(33%),随后有所下降。RP Gleason总分中位数(范围)为7(4 - 9)。536例男性患者中,252例(47%)活检Gleason评分与前列腺切除术后Gleason评分相关,其中170例(32%)较低,113例(21%)较高。肿瘤体积中位数为2 mL(浸润性腺泡灶 - 31 mL),前列腺内外切缘阳性率为52%。肿瘤体积和前列腺外切缘阳性率均随时间下降。

结论

该英国系列研究的术前特征和病理结果与其他未筛查人群的报道队列相似。前列腺外手术切缘阳性、肿瘤体积和分期的发生率随时间下降。

相似文献

1
Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time.根治性前列腺切除术:1001例病例的病理结果与其他主要系列研究的比较及随时间变化情况
BJU Int. 2005 Jan;95(1):34-9. doi: 10.1111/j.1464-410X.2005.05245.x.
2
Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.对于接受根治性前列腺切除术治疗临床局限性前列腺癌的患者,肿瘤体积是前列腺特异性抗原复发的独立预测因素。
BJU Int. 2006 Jun;97(6):1169-72. doi: 10.1111/j.1464-410X.2006.06148.x.
3
Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan.阳性活检核心的百分比、术前前列腺特异性抗原(PSA)水平、pT和Gleason评分作为根治性前列腺切除术后PSA复发的预测指标:日本一项多机构结局研究
BJU Int. 2006 Sep;98(3):549-53. doi: 10.1111/j.1464-410X.2006.06379.x.
4
Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.经尿道活检或切除诊断的前列腺导管腺癌并不总是提示侵袭性疾病:对临床管理的影响。
BJU Int. 2010 Feb;105(4):476-80. doi: 10.1111/j.1464-410X.2009.08812.x. Epub 2009 Aug 25.
5
Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.术前Gleason评分为8至10分的前列腺癌患者根治性前列腺切除术后的临床和病理结果。
Cancer. 2006 Sep 15;107(6):1265-72. doi: 10.1002/cncr.22116.
6
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.自前列腺特异性抗原检测出现以来,针对临床晚期(cT3)前列腺癌的根治性前列腺切除术:15年的结果。
BJU Int. 2005 Apr;95(6):751-6. doi: 10.1111/j.1464-410X.2005.05394.x.
7
Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.对于具有不良病理特征的前列腺癌患者,根治性前列腺切除术后辅助放疗可改善生化结局。
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24. doi: 10.1016/j.ijrobp.2004.06.018.
8
Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.前列腺特异性抗原水平在2.6至4.0 ng/ml与4.1至6.0 ng/ml之间的T1c期前列腺癌男性患者接受根治性前列腺切除术后的病理结果和生化进展情况。
J Urol. 2006 Aug;176(2):554-8. doi: 10.1016/j.juro.2006.03.058.
9
A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.机器人辅助腹腔镜根治性前列腺切除术与开放性耻骨后根治性前列腺切除术中阳性手术切缘的发生率及位置比较。
J Urol. 2007 Dec;178(6):2385-9; discussion 2389-90. doi: 10.1016/j.juro.2007.08.008. Epub 2007 Oct 22.
10
Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?当代经直肠前列腺活检能否准确筛选出适合前列腺癌半消融聚焦治疗的患者?
BJU Int. 2009 Jul;104(2):195-9. doi: 10.1111/j.1464-410X.2009.08347.x. Epub 2009 Feb 3.

引用本文的文献

1
The Challenges of Patient Selection for Prostate Cancer Focal Therapy: A Retrospective Observational Multicentre Study.前列腺癌局部治疗中患者选择的挑战:一项回顾性观察性多中心研究。
Curr Oncol. 2022 Sep 22;29(10):6826-6833. doi: 10.3390/curroncol29100538.
2
Predicting the Risk of Metastases by PSMA-PET/CT-Evaluation of 335 Men with Treatment-Naïve Prostate Carcinoma.通过PSMA-PET/CT评估335例未经治疗的前列腺癌男性患者转移风险
Cancers (Basel). 2021 Mar 25;13(7):1508. doi: 10.3390/cancers13071508.
3
The correlation between the gleason score of the biopsy and that of the prostatectomy patch.
活检的Gleason评分与前列腺切除术组织块的Gleason评分之间的相关性。
Ann Med Surg (Lond). 2021 Feb 26;63:102169. doi: 10.1016/j.amsu.2021.02.015. eCollection 2021 Mar.
4
Predictive value of Prostate Specific Antigen variations in the last week of salvage radiotherapy for biochemical recurrence of prostate cancer after surgery: A practical approach.前列腺特异性抗原变化在手术治疗后生化复发的挽救性放疗最后一周的预测价值:一种实用方法。
Cancer Rep (Hoboken). 2020 Dec;3(6):e1285. doi: 10.1002/cnr2.1285. Epub 2020 Sep 3.
5
Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study.雄激素剥夺疗法在前列腺癌患者前列腺切除术放疗期间和之后的应用:一项病例对照研究。
BMC Cancer. 2018 Mar 9;18(1):271. doi: 10.1186/s12885-018-4189-9.
6
Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): ability to predict cancer progression and decision-making regarding adjuvant therapy after radical prostatectomy.前列腺癌风险评估(CAPRA)术前评分与术后评分(CAPRA-S):预测癌症进展的能力及根治性前列腺切除术后辅助治疗的决策制定。
J Korean Med Sci. 2014 Sep;29(9):1212-6. doi: 10.3346/jkms.2014.29.9.1212. Epub 2014 Sep 2.
7
The role of postoperative radiotherapy in prostate cancer patients.术后放疗在前列腺癌患者中的作用。
Contemp Oncol (Pozn). 2013;17(5):413-20. doi: 10.5114/wo.2013.37215. Epub 2013 Oct 11.
8
Complications and functional results of surgery for locally advanced prostate cancer.局部晚期前列腺癌手术的并发症及功能结果
Adv Urol. 2012;2012:706309. doi: 10.1155/2012/706309. Epub 2012 Jan 12.
9
Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: continuous survey.基于人群的时间趋势和英国某地区前列腺癌放疗和根治性手术使用的社会经济变化:连续调查。
BMJ. 2010 Apr 21;340:c1928. doi: 10.1136/bmj.c1928.
10
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study.Ki-67与临床局限性前列腺癌的预后:来自跨大西洋前列腺癌研究组保守治疗前列腺癌患者的分析
Br J Cancer. 2009 Mar 24;100(6):888-93. doi: 10.1038/sj.bjc.6604951.